Guidelines for locoregional therapy in primary breast cancer in developing countries: The results of an expert panel at the 8th Annual Women's Cancer Initiative – Tata Memorial Hospital (WCI-TMH) Conference
暂无分享,去创建一个
R. Sarin | J. Yarnold | B. Anderson | I. Mittra | A. Munshi | Suresh C. Sharma | M. Thakur | R. Badwe | Sudeep Gupta | R. Jalali | V. Parmar | S. Desai | G. Baijal | J. Ghosh | Suresh C. Sharma
[1] R. Dikshit,et al. Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] A. Derossis,et al. Is Breast Cancer the Same Disease in Asian and Western Countries? , 2010, World Journal of Surgery.
[3] R. Moineddin,et al. Population-based longitudinal study of follow-up care for breast cancer survivors. , 2010, Journal of oncology practice.
[4] Andrew Hanby,et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial , 2010, The Lancet.
[5] L. Layfield,et al. Initial margin status for invasive ductal carcinoma of the breast and subsequent identification of carcinoma in reexcision specimens. , 2010, Archives of pathology & laboratory medicine.
[6] H. Bartelink,et al. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) , 2010, Acta oncologica.
[7] R. Badwe,et al. Low axillary sampling in clinically node-negative operable breast cancer. , 2009, The National medical journal of India.
[8] T. Julian,et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). , 2009, International journal of radiation oncology, biology, physics.
[9] R. Gelber,et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] R. Sarin,et al. Do all patients of breast carcinoma need 3-dimensional CT-based planning? A dosimetric study comparing different breast sizes. , 2009, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[11] A. Munshi,et al. Factors influencing cosmetic outcome in breast conservation. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).
[12] J. Smallwood,et al. Diagnosis and treatment of early breast cancer, including locally advanced disease—summary of NICE guidance , 2009, BMJ : British Medical Journal.
[13] Krystyna Kiel,et al. Breast cancer. Clinical practice guidelines in oncology. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.
[14] C. Perez,et al. Breast radiation therapy guideline implementation in low‐ and middle‐income countries , 2008, Cancer.
[15] Les Irwig,et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Lang. Placement of Radiopaque Clips for Tumor Localization in Patients Undergoing Neoadjuvant Chemotherapy and Breast Conservation Therapy , 2008 .
[17] Wayne Beckham,et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Yarnold,et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet. Oncology.
[19] J R Yarnold,et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet.
[20] D. Lannin,et al. Breast tattoos for planning surgery following neoadjuvant chemotherapy. , 2007, American journal of surgery.
[21] S. Jolly,et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. , 2007, International journal of radiation oncology, biology, physics.
[22] S. Leinster,et al. A comparison of the cosmetic and psychological outcome of breast reconstruction, breast conserving surgery and mastectomy without reconstruction. , 2007, Breast.
[23] S. Feigenberg,et al. Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection. , 2007, International journal of radiation oncology, biology, physics.
[24] C. Robles-Vidal,et al. A 7 year experience with immediate breast reconstruction after skin sparing mastectomy for cancer. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[25] J. Overgaard,et al. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] Richard Symonds-Tayler,et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] M. Cronin,et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Irene L Andrulis,et al. HER2 and responsiveness of breast cancer to adjuvant chemotherapy. , 2006, The New England journal of medicine.
[29] U. Chetty,et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.
[30] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[31] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[32] E. Berthelet,et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. , 2005, International journal of radiation oncology, biology, physics.
[33] L. Esserman. Integration of imaging in the management of breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] T. Buchholz. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial , 2005 .
[35] Kathleen R Gundry,et al. The application of breast MRI in staging and screening for breast cancer. , 2005, Oncology.
[36] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[37] F. Vicini,et al. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. , 2004, International journal of radiation oncology, biology, physics.
[38] H. Bartelink,et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[39] G. Hortobagyi,et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] A. Luini,et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. , 2003, Breast.
[41] G. Hortobagyi,et al. Neoadjuvant chemotherapy for breast carcinoma , 2003, Cancer.
[42] G. O'leary,et al. Cystic Cervical Metastases: Incidence and Diagnosis using Fine Needle Aspiration Biopsy , 2002, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[43] I. Barillot,et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.
[44] N. Cascinelli,et al. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. , 2001, Journal of the National Cancer Institute.
[45] S. Paik,et al. HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15. , 2000, Journal of the National Cancer Institute.
[46] S. Ciatto,et al. Intensive vs Clinical Follow-up After Treatmentof Primary Breast Cancer: 10-Year Updateof a Randomized Trial , 1999 .
[47] D. Schultz,et al. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. , 1999, International journal of radiation oncology, biology, physics.
[48] N. Le,et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. , 1997, The New England journal of medicine.
[49] K. Zedeler,et al. Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .
[50] R. Weichselbaum,et al. Breast preservation in stage I and II carcinoma of the breast: The University of Chicago experience , 1996 .
[51] D. Mant,et al. Routine follow up of breast cancer in primary care: randomised trial , 1996, BMJ.
[52] B. Haffty,et al. Long-term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy. , 1996, International journal of radiation oncology, biology, physics.
[53] R. Arriagada,et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] R. Steele,et al. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy , 1995, The British journal of surgery.
[55] J E Mortimer,et al. Factors influencing cosmetic results after conservation therapy for breast cancer. , 1995, International journal of radiation oncology, biology, physics.
[56] I. Fentiman,et al. Effect of menstrual phase on surgical treatment of breast cancer , 1994, The Lancet.
[57] A. Luini,et al. Effect of menstrual phase on surgical treatment of breast cancer , 1994, The Lancet.
[58] R. Sarin,et al. Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. , 1993, International journal of radiation oncology, biology, physics.
[59] C. Redmond,et al. Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants , 1993, Cancer.
[60] R. Senie,et al. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. , 1991, Annals of internal medicine.
[61] N. Barnard. Diseases of the Breast , 1986 .
[62] A. Luini,et al. Local control and survival in early breast cancer: the Milan trial. , 1986, International journal of radiation oncology, biology, physics.
[63] D. Goffinet,et al. Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy , 1982, Cancer.
[64] T. Eberlein. Menstrual Cycle and Surgical Treatment of Breast Cancer: Findings From the NCCTG N9431 Study , 2011 .
[65] F. Cardoso,et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[66] Robert B Livingston,et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. , 2010, The Lancet. Oncology.
[67] T. Julian,et al. Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] R. Sarin,et al. Breast conservation treatment in women with locally advanced breast cancer - experience from a single centre. , 2006, International journal of surgery.
[69] R. Prescott,et al. Re: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. , 2004, Journal of the National Cancer Institute.
[70] J. Bryant,et al. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. , 2002, Cancer.
[71] Jong-Hyeon Jeong,et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002, The New England journal of medicine.
[72] B. Haffty,et al. Negative margin status improves local control in conservatively managed breast cancer patients. , 2000, The cancer journal from Scientific American.
[73] S. Ciatto,et al. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. , 1999, JAMA.
[74] R. Orr. The Impact of Prophylactic Axillary Node Dissection on Breast Cancer Survival—A Bayesian Meta-Analysis , 1999, Annals of surgical oncology.
[75] A. Hanlon,et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. , 1998, International journal of radiation oncology, biology, physics.
[76] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.